Compare ADMA Biologics Inc (ADMA) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Prudential PLC — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Prudential PLC trades at $27.79 (market cap $34.02B). The key difference: Prudential PLC is far larger — about 15.3× ADMA Biologics Inc's market cap, and Prudential PLC pays a 1.94% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | PUK | |
|---|---|---|
Market Cap | $2.22B | $34.02B |
Sector | Health | Financials |
52-Week High | $20.38 | $33.61 |
52-Week Low | $7.60 | $24.98 |
Enterprise Value | $2.29B | $35.46B |
Dividend Yield | — | 1.94% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
